These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6247969)

  • 21. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
    Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
    Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
    Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.
    Field HJ; Larder BA; Darby G
    Am J Med; 1982 Jul; 73(1A):369-71. PubMed ID: 6285724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sensitivities to other antiviral drugs and thymidine kinase activity of aciclovir-resistant herpes simplex virus type 1].
    Nitta K; Shiota H; Naito T; Mimura Y
    Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):513-9. PubMed ID: 8030564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
    Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a thymidine kinase inhibitor (L-653,180) on antiviral treatment of experimental herpes simplex virus infection in mice.
    Klein RJ; Czelusniak SM
    Antiviral Res; 1990; 14(4-5):207-14. PubMed ID: 2088206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
    Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
    J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
    Ellis MN; Keller PM; Fyfe JA; Martin JL; Rooney JF; Straus SE; Lehrman SN; Barry DW
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1117-25. PubMed ID: 2821890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.
    Klein RJ; DeStefano E; Friedman-Kien AE; Brady E
    Antimicrob Agents Chemother; 1981 May; 19(5):937-9. PubMed ID: 6271054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates.
    Shin YK; Cai GY; Weinberg A; Leary JJ; Levin MJ
    J Clin Microbiol; 2001 Mar; 39(3):913-7. PubMed ID: 11230403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
    Tenser RB; Gaydos A; Hay KA
    J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of sensitivity of acyclovir of herpes simplex virus clinical isolates.
    McLaren C; Sibrack CD; Barry DW
    Am J Med; 1982 Jul; 73(1A):376-9. PubMed ID: 6285726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir.
    Collins P; Ellis MN
    J Med Virol; 1993; Suppl 1():58-66. PubMed ID: 8245894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herpes simplex virus antiviral drug resistance--current trends and future prospects.
    Field HJ
    J Clin Virol; 2001 Jun; 21(3):261-9. PubMed ID: 11397663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-frequency phenotypic reversion and pathogenicity of an acyclovir-resistant herpes simplex virus mutant.
    Griffiths A; Coen DM
    J Virol; 2003 Feb; 77(3):2282-6. PubMed ID: 12525666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary characterization of a mutant of herpes simplex virus type 1 selected for acycloguanosine resistance in vitro.
    Palú G; Summers WP; Valisena S; Tognon M
    J Med Virol; 1988 Mar; 24(3):251-62. PubMed ID: 2835423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported.
    Inagaki T; Satoh M; Fujii H; Yamada S; Shibamura M; Yoshikawa T; Harada S; Takeyama H; Saijo M
    Jpn J Infect Dis; 2018 Sep; 71(5):343-349. PubMed ID: 29848849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence.
    Omura N; Fujii H; Yoshikawa T; Yamada S; Harada S; Inagaki T; Shibamura M; Takeyama H; Saijo M
    Virol J; 2017 Mar; 14(1):59. PubMed ID: 28320407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus variants restraint to high concentrations of acyclovir exist in clinical isolates.
    Parris DS; Harrington JE
    Antimicrob Agents Chemother; 1982 Jul; 22(1):71-7. PubMed ID: 6289742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
    Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
    Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.